Clinical Trial: A Prospective, Single-Arm,Multicenter Clinical Study of Orelabrutinib in Combination with Pola-R-miniCHP (OPR-miniCHP) for the Treatment of Previously Untreated Older Adults with High-Risk Diffuse Large B-Cell Lymphoma (China)

China, Sept. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Single-Arm,Multicenter Clinical Study of Orelabrutinib in Combination with Pola-R-miniCHP (OPR-miniCHP) for the Treatment of Previously Untreated Older Adults with High-Risk Diffuse Large B-Cell Lymphoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133211

Registration Time: 2026/09/23

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital, College of Medicine, Zhejiang University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334319

Published by HT Digital Content Services with permission from Health Daily Digest...